$ALPS News
Last published 1d ago
- 1d agoALPSAlps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction TestingGlobeNewswirePCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Science
- 6d agoALPSTrading halt: ALPS Group Inc Ordinary Share (ALPS), News pendingNasdaq Trading HaltsHalted 2026-11-06 19:50:00.000 ET, resumption quote none, resumption trade none.
- 2w agoALPSAlps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of AssociationGlobeNewswireKUALA LUMPUR, Malaysia, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that
- 3mo agoALPSAlps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business UpdateGlobeNewswireRevenue Grew 44% to $4.9 Million, Led by Continued Growth Across Cellular Therapy, Medical Testing, Laboratory and Aesthetics Beauty Services, and Healthcare Products Began Trading on the Nasdaq Global Market Under the
- 4mo agoALPSAlps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast AsiaGlobeNewswireKUALA LUMPUR, Malaysia, June 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced its
- 5mo agoALPSAlps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022GlobeNewswireKUALA LUMPUR, Malaysia, June 09, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc ("Alps" or "the Company") (NASDAQ:ALPS), an integrated biotechnology platform headquartered in Malaysia, today announced that its subsidiary,
- 5mo agoALPSAlps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireKUALA LUMPUR, Malaysia, May 19, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology research and
- 7mo agoALPSAlps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets OversightGlobeNewswireKUALA LUMPUR, Malaysia, April 17, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a biotechnology research and healthcare platform
- 8mo agoALPSAlps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture ProtocolGlobeNewswireKUALA LUMPUR, Malaysia, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology research and
- 9mo agoALPSAlps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome TherapyGlobeNewswireKUALA LUMPUR, Malaysia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (the "Company" or "Alps Group"), the parent company of Alps Life Sciences Inc. ("Alps Holdco"), a fully integrated biotechnology research and
- 10mo agoALPSAlps Group Inc Appoints Cheing Lye-Ping as Chief Financial OfficerGlobeNewswireKUALA LUMPUR, Malaysia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (NASDAQ:ALPS) (the "Company" or "Alps Group"), a fully integrated biotechnology research and healthcare platform specializing in predictive,